Package 62032-925-01

{"spl_id": "d740305e-a23a-4960-9577-f41144e55558", "openfda": {"spl_set_id": ["a64045dd-8f70-43f1-be6f-ad1556c0e210"], "manufacturer_name": ["Obagi Cosmeceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 BAG (62032-925-01)  *  57 g in 1 BOTTLE, PLASTIC *  57 g in 1 BOTTLE, PLASTIC *  48 g in 1 BOTTLE, PLASTIC *  1 TUBE in 1 CARTON (62032-811-09)  / 85 g in 1 TUBE *  57 g in 1 BOTTLE, PLASTIC *  198 mL in 1 BOTTLE, PLASTIC *  198 mL in 1 BOTTLE, PLASTIC", "package_ndc": "62032-925-01", "marketing_start_date": "20250625"}], "brand_name": "Obagi Nu-Derm Fx System Normal-Oily Skin Transformation Complexion Brightening System", "product_id": "62032-925_d740305e-a23a-4960-9577-f41144e55558", "dosage_form": "KIT", "product_ndc": "62032-925", "generic_name": "Titanium Dioxide, Zinc Oxide", "labeler_name": "Obagi Cosmeceuticals LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Obagi Nu-Derm Fx System Normal-Oily Skin Transformation", "brand_name_suffix": "Complexion Brightening System", "application_number": "M020", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250625", "listing_expiration_date": "20261231"}